Celldex Therapeutics
CLDX
#4503
Rank
A$3.55 B
Marketcap
A$45.25
Share price
4.75%
Change (1 day)
29.71%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2026 (TTM): -A$0.49 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are A$0.15 Million. In 2025 the company made an earning of -A$0.42 Billion a decrease over its 2024 earnings that were of -A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.49 Billion15.53%
2025 -A$0.42 Billion47.31%
2024 -A$0.29 Billion37.34%
2023 -A$0.21 Billion32.63%
2022 -A$0.16 Billion54.88%
2021 -A$0.11 Billion39.49%
2020 -A$71.7 Million-9.08%
2019 -A$78.86 Million-28.64%
2018 -A$0.12 Billion-30.11%
2017 -A$0.16 Billion-17.75%
2016 -A$0.2 Billion4.5%
2015 -A$0.19 Billion4.09%
2014 -A$0.18 Billion51.57%
2013 -A$0.12 Billion40.1%
2012 -A$83.23 Million
2010 -A$1.81 Million-96.59%
2009 -A$52.94 Million
2006 -A$32.35 Million
2004 -A$19.65 Million15.75%
2003 -A$16.97 Million-18.69%
2002 -A$20.88 Million-41.22%
2001 -A$35.51 Million59%
2000 -A$22.34 Million27.65%
1999 -A$17.5 Million53.12%
1998 -A$11.43 Million2.6%
1997 -A$11.14 Million-33.62%
1996 -A$16.78 Million-1.69%
1995 -A$17.07 Million22.92%
1994 -A$13.89 Million-0%
1993 -A$13.89 Million
1991 -A$8.54 Million90.32%
1990 -A$4.49 Million10.71%
1989 -A$4.05 Million833.33%
1988 -A$0.44 Million-400%
1987 A$0.14 M-125%
1986 -A$0.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$9.98 B-2,219.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.87 B-3,257.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.34 B-2,295.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-A$4.06 Million-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.15 Billion 142.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.21 B-146.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion-70.81%๐Ÿ‡บ๐Ÿ‡ธ USA